Esperion Gets $33M To Continue Work On Cholesterol BusterThe Ann Arbor biotech firm Esperion Therapeutics Inc. announced that it has completed a $33 million preferred stock financing led by new investor Longitude Capital.
Event Notices From June 24-26The latest event and meeting notices from Michigan's technology-focused companies and institutions

More From CBS Detroit

Best Places To See Indie Rock In DetroitIt's called Detroit Rock City for a reason.
Best Ice Cream Shops In Metro DetroitIt's getting warm outside! Take advantage of it.
Best Hiking Trails In Metro DetroitGet out there and enjoy this unseasonably warm weather!

Watch & Listen